55 related articles for article (PubMed ID: 6098229)
1. The effect of stimulation of pre- and postsynaptic dopamine receptors on the endogenous inhibitor of cAMP-dependent protein kinase.
Szmigielski A; Kowner A
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):205-13. PubMed ID: 6098229
[TBL] [Abstract][Full Text] [Related]
2. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
Szmigielski A; Szadowska A; Szmigielska H
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
[TBL] [Abstract][Full Text] [Related]
3. The responsiveness of the endogenous inhibitor of cAMP-dependent protein kinase to apomorphine in rat striatum after prolonged treatment with nomifensin.
Szmigielski A; Szmigielska H; Zalewska J
Pol J Pharmacol Pharm; 1985; 37(3):285-93. PubMed ID: 4070079
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between D1- and D2-dopamine receptors in the nucleus accumbens.
Szmigielski A; Zalewska-Kaszubska J
Neuropharmacology; 1991 Mar; 30(3):259-66. PubMed ID: 1830133
[TBL] [Abstract][Full Text] [Related]
5. Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina.
Nowak JZ; Zawilska J; Sek B; Schorderet M
Pol J Pharmacol Pharm; 1990; 42(5):457-70. PubMed ID: 1983030
[TBL] [Abstract][Full Text] [Related]
6. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
7. The responsiveness of D1- and D2-dopamine receptors in the striatum and hypothalamus of spontaneous and vasopressin hypertensive rats.
Szmigielska H; Szmigielski A; Szadowska A
Pol J Pharmacol Pharm; 1992; 44(4):355-64. PubMed ID: 1287599
[TBL] [Abstract][Full Text] [Related]
8. Isoprenaline-induced changes in type I inhibitor activity as an index of beta-adrenergic receptor subsensitivity.
Szmigielski A; Zawilska J; Kondracki K
Pol J Pharmacol Pharm; 1984; 36(2-3):281-91. PubMed ID: 6089161
[TBL] [Abstract][Full Text] [Related]
9. Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.
McMillen BA; German DC; Sanghere MK; Warnack W; Shore PA
J Pharmacol Exp Ther; 1980 Oct; 215(1):150-5. PubMed ID: 6109013
[TBL] [Abstract][Full Text] [Related]
10. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
Pradhan N; Arunasmitha AS
Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
Misu Y; Goshima Y; Ueda H; Kubo T
J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
[TBL] [Abstract][Full Text] [Related]
12. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
13. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
Hársing LG; Vizi ES
Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
Okuyama S; Shimamura H; Hashimoto S; Aihara H
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
16. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
Lokhandwala MF; Steenberg ML
J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the activity of endogenous protein kinase inhibitors in rat heart by the beta adrenergic receptor.
Szmigielski A
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):64-71. PubMed ID: 6261707
[TBL] [Abstract][Full Text] [Related]
18. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]